Home > News > Nanoscale “Cell Within A Cell”
August 1st, 2005
Nanoscale “Cell Within A Cell”
Abstract:
Imagine a cancer drug that can burrow into a tumor, seal the exits and detonate a lethal dose of anticancer toxins, all while leaving healthy cells unscathed. Investigators at the Massachusetts Institute of Technology have designed a multifunctional nanoparticle to do just that. The dual-chamber, double-acting, drug-packing "nanocell" proved effective and safe, with prolonged survival, against two distinct forms of cancers-melanoma and Lewis lung cancer-in mice. This work, conducted by a multidisciplinary team led by Ram Sasisekharan, Ph.D., of MIT, was published in the journal Nature.
The nanocell worked better against melanoma than lung cancer, indicating the need to tweak the design for different cancers. "This model enables us to rationally and systematically evaluate drug combinations and loading mechanisms," says Dr. Sasisekharan. "It's not going to stop here. We want to build on this concept."
Source:
nano.cancer.gov
Bookmark:
| Related Links |
Massachusetts Institute of Technology
| Related News Press |
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||